Jules Bordet Institute
Clinical trials sponsored by Jules Bordet Institute, explained in plain language.
-
New drug cocktail before radiation shows promise against rectal cancer
Disease control OngoingThis study tests whether giving two drugs (nivolumab and regorafenib) before and after a short course of radiation can shrink tumors in people with stage II or III rectal cancer. About 72 participants will receive the treatment, then either have surgery or be closely watched if t…
Phase: PHASE2 • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Blood test may predict when colorectal cancer treatment fails
Knowledge-focused OngoingThis study looks at whether changes in tumor DNA found in the blood (ctDNA) can predict if chemotherapy is working in people with advanced colorectal cancer that no longer responds to standard treatments. About 103 participants will give blood samples and have regular scans to tr…
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC